���景与受体作用机制 — Reference Sheet

By Editorial Desk · published 2026-06-03 · last reviewed 2026-07-12 · Guide

ipamorelin raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.

Reviewed 2026-07-12. Anything still debated is marked as such rather than presented as settled.

背景与受体作用机制

现有文献多来自小规模、短期的研究，涉及生长激素缺乏、术后肠麻痹等方向。长期使用是否导致受体脱敏，以及重复给药后效应是否衰减，仍属开放问题。不同研究之间的剂量、给药途径和受试者特征差异较大，因此结论外推需谨慎。关于临床获益的确切证据尚不充分，需要更大规模的对照试验来澄清。

Ipamorelin 是一种合成五肽，在 20 世纪 90 年代被报道为生长激素促分泌剂。其结构基于胃饥饿素受体激动剂的设计思路，但并非天然激素。早期药理学研究显示，它可刺激垂体释放生长激素，而对应激激素轴的影响相对较小。该化合物常被用作研究生长激素调节通路的工具分子。

在机制层面，ipamorelin 与生长激素促分泌受体 1a 型结合，该受体也介导胃饥饿素的多种效应。受体激活后，细胞内信号促进生长激素从垂体前叶释放。由于对促肾上腺皮质激素和皮质醇的刺激较弱，它被视为选择性较高的促分泌剂。这种选择性在动物模型和少量人体研究中被观察到，但人体数据仍然有限。

Background And Receptor Mechanism

At the molecular level, ipamorelin acts as an agonist at the growth hormone secretagogue receptor, also called the ghrelin receptor or GHS-R1a. Binding to this receptor on pituitary somatotroph cells triggers a signaling cascade that leads to growth hormone release. The effect is mediated through phospholipase C and calcium mobilization rather than through the cyclic AMP pathway used by growth hormone releasing hormone. The two pathways are complementary, and combined stimulation produces a larger response than either alone.

Compared with other secretagogues such as GHRP-2, GHRP-6, and hexarelin, ipamorelin is described as more selective. Published animal work reports little or no increase in adrenocorticotropic hormone, cortisol, or prolactin at doses that release growth hormone. This selectivity is the property most often cited in the research literature. Whether the same profile holds across species and dosing schedules remains an open question, since human data are limited and come largely from small studies.

Ipamorelin at a glance

Background and Structural Identity

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Its sequence, Aib-His-D-2-Nal-D-Phe-Lys-NH2, combines three non-proteinogenic residues with a C-terminal amide. The N-terminal aminoisobutyric acid unit and the two aromatic D-amino acids distinguish it from peptides assembled only from standard L-amino acids. Its formula is C38H49N9O5, corresponding to an average mass near 711.9 Da. At neutral pH the molecule carries a net positive charge, a property that shapes its behaviour in chromatographic and electrophoretic systems.

The compound was developed at Novo Nordisk during the 1990s as part of a programme seeking secretagogues with improved selectivity. It was described in the peer-reviewed literature in 1998 alongside related pentapeptides from the same series. Investigators advanced it because it raised growth hormone output in animal models while leaving other pituitary hormones comparatively unaffected. The development code NNC 26-0161 appears in earlier reports, and ipamorelin later became the common designation in published work.

Related pages on this site

• Regional archive
• Proven update
• Professional report
• Reliable handbook
• Professional casebook
• Seasonal reference
• Efficient summary
• Lightweight analysis

Analytical Characterisation and Storage

Mass spectrometry confirms identity and reveals structural deviations that chromatography alone can miss. Positive-mode electrospray ionisation generally yields multiply charged ions whose deconvoluted mass is checked against the theoretical value. Amino acid analysis, and enzymatic digestion with subsequent fragment mapping, provide independent confirmation of sequence and of the terminal amide. Analysts take care to separate the target from deletion sequences, which may differ by one residue and therefore by only a small mass increment.

The lyophilised solid is normally held at -20 °C or colder, shielded from light and moisture. Stability in that state is measured in years, although shelf life depends on residual water content and the container seal. Once dissolved, the peptide is more fragile: aqueous solutions are commonly kept at 2-8 °C and used within days to weeks, and repeated freeze-thaw cycling is avoided. Strongly acidic or basic conditions accelerate hydrolysis, and prolonged exposure to them can strip the terminal amide.

Purity assessment for this peptide relies mainly on reversed-phase high-performance liquid chromatography. A C18 column with a water-acetonitrile gradient containing trifluoroacetic acid separates the target from truncated sequences and oxidation products. Detection near 214 nm exploits the amide backbone, while the aromatic side chains allow additional monitoring close to 280 nm. Reported purity values depend on the method, so a certificate of analysis carries weight only when gradient, column and integration parameters are given.

Notes from published material

=== EC 2.10: metal transferases === The category of EC 2.10 includes enzymes that transfer molybdenum or tungsten-containing groups. However, as of 2011, only one enzyme has been added: molybdopterin molybdotransferase. This enzyme is a component of MoCo biosynthesis in Escherichia coli. The reaction it catalyzes is as follows: adenylyl-molybdopterin + molybdate

=== Single-layer drug-in-adhesive === The adhesive layer of this system also contains the drug. In this type of patch the adhesive layer not only serves to adhere the various layers together, along with the entire system to the skin, but is also responsible for the releasing of the drug. The adhesive layer is surrounded by a temporary liner and a backing. It is characterized by the inclusion of the drug directly within the skin-contacting adhesive placed onto the epidermis.

== The industry == Within the chemical universe, the fine chemical industry is positioned between the commodity, their suppliers, and specialty chemical industries, their customers. Depending on the services offered, there are two types of fine chemical companies. Fine chemical companies are active in industrial scale production, both of standard and exclusive products. Fine chemical companies tend to fall into one of three categories: producers are referred to as Custom Manufacturing Organizations (CMOs); Contract Research Organizations (CROs)' main assets are their research laboratories; and CRAMS (Contract Research and Manufacturing Organizations are hybrids between the two.

An equianalgesic chart is a conversion chart that lists equivalent doses of analgesics (drugs used to relieve pain). Equianalgesic charts are used for calculation of an equivalent dose (a dose which would offer an equal amount of analgesia) between different analgesics. Tables of this general type are also available for NSAIDs, benzodiazepines, depressants, stimulants, anticholinergics and others. When using oral morphine as a baseline, the comparison of strengths of opioid analgesics is referred to as oral morphine equivalent.

Sources: en.wikipedia.org

Further detail

It is now known that the underlying physiological correlation for the increase in EPSP size is a postsynaptic upregulation of AMPARs at the membrane, which is accomplished through the interactions of AMPARs with many cellular proteins. The simplest explanation for LTP is as follows (see the long-term potentiation article for a much more detailed account). Glutamate binds to postsynaptic AMPARs and another glutamate receptor, the NMDA receptor (NMDAR). Ligand binding causes the AMPARs to open, and Na+ flows into the postsynaptic cell, resulting in a depolarization. NMDARs, on the other hand, do not open directly because their pores are occluded at resting membrane potential by Mg2+ ions. NMDARs can open only when a depolarization from the AMPAR activation leads to repulsion of the Mg2+ cation out into the extracellular space, allowing the pore to pass current. Unlike AMPARs, however, NMDARs are permeable to both Na+ and Ca2+. The Ca2+ that enters the cell triggers the upregulation of AMPARs to the membrane, which results in a long-lasting increase in EPSP size underlying LTP. The calcium entry also phosphorylates CaMKII, which phosphorylates AMPARs, increasing their single-channel conductance.

"[...] we commend the Anti-Eugenics Project for their essential work to understand[...] the harmful legacies of eugenicist ideologies. [...] examine the role that philanthropies played in developing and perpetuating eugenics policies and practices. The Rockefeller Foundation is currently reckoning with our own history in relation to eugenics. This requires uncovering the facts and confronting uncomfortable truths, [...] The Rockefeller Foundation is putting equity and inclusion at the center of all our work: [...] confronting the hateful legacies of the past [...] we understand that the work we engage in today does not absolve us of yesterday's mistakes. [...]"

middle lamella In plant cells, the outermost layer of the cell wall; a continuous, unified layer of extracellular pectins which is the first layer deposited by the cell during cytokinesis and which serves to cement together the primary cell walls of adjacent cells.

Sources: en.wikipedia.org

Background from the literature

==== Population and poverty crisis ==== Concerns about the population density in Puerto Rico can be traced back to 1898 when Puerto Rico became a US colony. These concerns from scholars, scientist, and government officials inform the thought process behind the association between poverty, health, and economy with population throughout the 20th century. When Americans began to occupy the island of Puerto Rico, they asserted more than their ideals and beliefs. American colonizers asserted absolute dominance over Puerto Rico due to the idea of Manifest Destiny, which greatly shifted the dynamics of the island. The U.S. capitalized on the fact that Puerto Rico utilized a large fraction of its resources to gain independence from Spain, which left the island's economy depleted. During this time, many Puerto Ricans lost land while their natural resources became exploited. In the mid-1920s, Puerto Rico's dependency on the production of sugar, devastated the island when the sugar market collapsed. Additionally, the nationwide economic depression in 1927 exacerbated the effects of this collapse as well as the overall stability of the island. In 1928, Puerto Rico suffered the consequences of a hurricane in San Felipe. The Okeechobee Hurricane resulted in over 300 deaths and property damages ranging from $50-$80 million, while the agricultural market also suffered. In the 1930s, Puerto Rican citizens began to experience the adverse health effects of tuberculosis, malaria, diarrhea-enteritis, hookworm, and dietary-deficiencies that were responsible for over 40 percent of deaths.

=== The World Health Organization === The World Health Organization considers two formulation bioequivalent if the 90% confidence interval for the ratio multisource (generic) product/comparator lie within 80.00–125.00% acceptance range for AUC0–t and Cmax. For high variable finished pharmaceutical products, the applicable acceptance range for Cmax can be expanded (up to 69.84–143.19%).

Governor William Robinson shared the same view with the former, insisted that a Medical Department with a Principal Civil Medical Officer directly under the Government should replace the Sanitary Board. With regard of the reconstitution of the Sanitary Board, Governor William Robinson conducted a plebiscite in June 1896. Besides the reconstitution of the Sanitary Board issues, in 1894 there was a group of petitioners supported by the Unofficial Members of the Legislative Council Paul Chater and Ho Kai with 363 signatures asked for a further representations in the Colonial Government. They demanded:

== Awards == Hackenberger has received numerous awards for his work, including the Heinz Maier-Leibnitz Prize of the German Research Foundation (2011), the ORCHEM Prize of the German Chemical Society (2012), the Zervas Award of the European Peptide Society (2018), the Breakthrough of the Year Award in the life sciences from the Falling Walls Foundation (2020), the Astra-Zeneca Award of the Royal Society of Chemistry (2023), the Xiaoyu Hu Memorial Award of the Chinese Peptide Society (2023), and the Max Bergmann Medal (2024).

Sources: en.wikipedia.org

Frequently asked questions